CEO: Lonnel Coats

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.


Key numbers

Market Capitalization:375140160
Shares Outstanding: 106272000
Float: 102806682.624
Next Earning Date:2020-02-28
TTm EPS: 1.5469
TTm Dividend Rate:
200 days moving average:4.65
50 days moving average: 3.34
One day percent Change: 13.6



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,